Aura Biosciences, Inc.

NASDAQ (USD): Aura Biosciences, Inc. (AURA)

Last Price

11.75

Today's Change

+1.46 (14.18%)

Day's Change

11.20 - 12.37

Trading Volume

734,298

Overview

Market Cap

580 Million

Shares Outstanding

49 Million

Avg Volume

157,554

Avg Price (50 Days)

8.60

Avg Price (200 Days)

8.12

PE Ratio

-6.54

EPS

-1.79

Earnings Announcement

07-Nov-2024

Previous Close

10.29

Open

11.45

Day's Range

11.202 - 12.3782

Year Range

5.99 - 12.3782

Trading Volume

734,613

Price Change Highlight

1 Day Change

13.70%

5 Day Change

39.78%

1 Month Change

22.51%

3 Month Change

32.65%

6 Month Change

65.72%

Ytd Change

29.57%

1 Year Change

37.32%

3 Year Change

-20.95%

5 Year Change

-20.95%

10 Year Change

-20.95%

Max Change

-20.95%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment